Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pianko

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Genes and Immunity|September 5, 2002
A genotypic association implicates myeloperoxidase in the progression of hepatic fibrosis in chronic hepatitis C virus infectionW F Reynolds, K Patel, S Pianko, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|November 26, 1999
A pilot study of daily subcutaneous interleukin-10 in patients with chronic hepatitis C infectionJ G McHutchison, G Giannelli, L Nyberg, et al.
Journal of Hepatology|February 24, 2001
The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivityJ G McHutchison, J E Ware, M S Bayliss, et al.
Gastroenterology|October 31, 2000
The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C. The International Hepatitis Interventional Therapy GroupJ G McHutchison, T Poynard, S Pianko, et al.
Alimentary Pharmacology & Therapeutics|May 20, 2003
Induction interferon and ribavirin for re-treatment of chronic hepatitis C patients unresponsive to interferon aloneW Sievert, R Batey, L Mollison, et al.
Journal of Viral Hepatitis|August 7, 2012
Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3S Pianko, S Zeuzem, W-L Chuang, et al.
Journal of Viral Hepatitis|March 16, 2013
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirinG R Foster, S Zeuzem, S Pianko, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Genes and Immunity|September 5, 2002
A genotypic association implicates myeloperoxidase in the progression of hepatic fibrosis in chronic hepatitis C virus infectionW F Reynolds, K Patel, S Pianko, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|November 26, 1999
A pilot study of daily subcutaneous interleukin-10 in patients with chronic hepatitis C infectionJ G McHutchison, G Giannelli, L Nyberg, et al.
Journal of Hepatology|February 24, 2001
The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivityJ G McHutchison, J E Ware, M S Bayliss, et al.
Gastroenterology|October 31, 2000
The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C. The International Hepatitis Interventional Therapy GroupJ G McHutchison, T Poynard, S Pianko, et al.
Alimentary Pharmacology & Therapeutics|May 20, 2003
Induction interferon and ribavirin for re-treatment of chronic hepatitis C patients unresponsive to interferon aloneW Sievert, R Batey, L Mollison, et al.
Journal of Viral Hepatitis|August 7, 2012
Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3S Pianko, S Zeuzem, W-L Chuang, et al.
Journal of Viral Hepatitis|March 16, 2013
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirinG R Foster, S Zeuzem, S Pianko, et al.
Pageof 2